As demonstrated by SARS-CoV-2, viruses have the potential to cause devastating economic and healthcare disruption on a global scale. We are interested in several structural aspects of influenza virus and bunyaviruses, both of which are negative-stranded RNA viruses.
Influenza virus is a current public health risk. 5-10% of adults are yearly affected by seasonal Influenza outbreaks, leading to up to 5 million cases of severe illness and 500,000 deaths worldwide. Additionally, Influenza can develop resistance to current antivirals and new strains can emerge and result in pandemics. We are interested in two aspects of the influenza virus replication cycle: 1) how influenza starts an infection within a cell, a process that requires the merging (fusion) of the viral and cellular membranes mediated by the viral hemagglutinin protein; and 2) how influenza’s 8 RNA segments bundle together to form an infectious particle, potentially resulting in novel pandemic influenza viruses. We are also developing strategies to detect and block influenza virus infections, by using a novel type of antibody-like proteins, termed Affimers.
On the other hand, bunyaviruses are emerging RNA viruses that cause significant disease and economic burden and for which vaccines or therapies approved for human use do not exist. We are interested in 3 aspects of the bunyavirus life cycle: 1) We have studied the requirement of endosomal ions for enveloped virus fusion and found that K+ ions induce conformational changes in the viral fusion proteins of bunyaviruses, enhancing interactions with the target membrane. 2) We aim to understanding the structure of the viral genome, which is wrapped up by the nucleoprotein (NP) to form a flexible chain called a ribonucleoprotein (RNP). And 3) we aim to understand how the virus remodels the cell host membranes in order to establish replication factories.
To answer these research questions we employ a combination of state-of-the-art electron microscopy (including cryo-electron microscopy and correlative light-electron microscopy) and molecular biology.
Applications are welcomed from self-funded students or from students who have a sponsor who will provide their funding.
You should hold a first degree equivalent to at least a UK upper-second class honours degree or a MSc degree in a relevant subject. This project would suit someone with a strong background in tissue engineering, cancer biology or closely-related areas. Additional experience of conducting research in a multidisciplinary setting is highly desirable. Upon completion of the PhD, the successful candidate will be uniquely equipped for high-demand careers within academia or industry with desirable skills in bioengineering, regenerative medicine and cancer/cell biology.
Applicants whose first language is not English must provide evidence that their English language is sufficient to meet the specific demands of their study. The Faculty of Biological Sciences minimum requirements in IELTS and TOEFL tests are:
- British Council IELTS - score of 6.0 overall, with no element less than 5.5
- TOEFL iBT - overall score of 87 with the listening and reading element no less than 20, writing element no less than 21 and the speaking element no less than 22.
How to apply:
To apply for this project applicants should complete an online application form and attach the following documentation to support their application.
- a full academic CV
- degree certificate and transcripts of marks
- Evidence that you meet the University's minimum English language requirements (if applicable).
- Evidence of funding
To help us identify that you are applying for this project please ensure you provide the following information on your application form;
- Select PhD in Biological Sciences as your programme of study
- Give the full project title and name the supervisors listed in this advert
To find out more about the research in Dr Juan Fontana’s lab, you can email J.Fontana@leeds.ac.uk